πŸ‡ΊπŸ‡Έ FDA
Patent

US 9982025

Monomeric griffithsin tandemers

granted A61KA61K38/00A61K47/55

Quick answer

US patent 9982025 (Monomeric griffithsin tandemers) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K47/55, A61K47/59, A61K47/60